Polycystic Ovary Syndrome

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Advances in Psychiatry and Behavioral Health

• Publication date

  2023-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.ypsc.2023.03.014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Polycystic Ovary Syndrome (PCOS) and Non-Suicidal Self-Injury (NSSI): A Community-Based Study

  2022cited by this paper
• Cognitive behavioural therapy for depression in women with PCOS: systematic review and meta-analysis.

  2022cited by this paper
• The effects of cognitive behavioral therapy in women with polycystic ovary syndrome: A meta-analysis

  2022cited by this paper
• Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome

  2021cited by this paper
• Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone

  2021cited by this paper
• Testosterone in Female Depression: A Meta-Analysis and Mendelian Randomization Study

  2021cited by this paper
• Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome

  2021cited by this paper
• Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial

  2021cited by this paper
• Progesterone, reproduction, and psychiatric illness.

  2020cited by this paper
• Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study

  2020cited by this paper
• Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program

  2020cited by this paper
• Population-based data at ages 31 and 46 show decreased HRQoL and life satisfaction in women with PCOS symptoms.

  2020cited by this paper
• Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): A systematic review and meta‐analysis

  2020cited by this paper
• Persistent risk: psychological comorbidity in polycystic ovary syndrome

  2020cited by this paper
• Update on PCOS: Consequences, Challenges and Guiding Treatment.

  2020cited by this paper
• Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen

  2020cited by this paper
• Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis

  2018cited by this paper
• Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome.

  2018cited by this paper
• Cognitive-behavioral therapy improves weight loss and quality of life in women with polycystic ovary syndrome: a pilot randomized clinical trial.

  2018cited by this paper
• Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies

  2018cited by this paper
• Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome

  2018cited by this paper
• An exploration of the hypothesis that testosterone is implicated in the psychological functioning of women with polycystic ovary syndrome (PCOS).

  2018cited by this paper
• Effects of Metformin on Symptoms of Polycystic Ovarian Syndrome Among Women of Reproductive Age

  2018cited by this paper
• A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome

  2018cited by this paper
• Effectiveness of cognitive-behavioral therapy (CBT) in improving the quality of life and psychological fatigue in women with polycystic ovarian syndrome: a randomized controlled clinical trial

  2018cited by this paper
• Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis

  2018cited by this paper
• Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome.

  2017cited by this paper
• Risk of developing obstructive sleep apnea among women with polycystic ovarian syndrome: a nationwide longitudinal follow-up study.

  2017cited by this paper
• Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment

  2017cited by this paper
• High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis

  2017cited by this paper
• Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort.

  2016cited by this paper
• Premenstrual Dysphoric Disorder: Epidemiology and Treatment

  2015cited by this paper
• Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome

  2015cited by this paper
• AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

  2015cited by this paper
• Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: a randomized controlled trial

  2015cited by this paper
• Body satisfaction and eating attitudes among girls and young women with and without polycystic ovary syndrome.

  2014cited by this paper
• Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects

  2014cited by this paper
• Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study

  2014cited by this paper
• Body Image, Self-Esteem and Depressive Symptomatology in Women with Polycystic Ovary Syndrome.

  2014cited by this paper
• Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression.

  2013cited by this paper
• Assessment and management of polycystic ovary syndrome: summary of an evidence‐based guideline

  2011cited by this paper
• Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome.

  2011cited by this paper
• Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome.

  2011cited by this paper
• Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls

  2011cited by this paper
• Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index.

  2010cited by this paper
• Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study.

  2009cited by this paper
• Women with polycystic ovary syndrome are often depressed or anxious--a case control study.

  2008cited by this paper
• Increased risk of depressive disorders in women with polycystic ovary syndrome.

  2007cited by this paper
• Polycystic ovary syndrome

  2007cited by this paper
• Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome.

  2007cited by this paper
• Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality.

  2006cited by this paper
• Depression and Body Image among Women with Polycystic Ovary Syndrome

  2006cited by this paper
• Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome.

  2005cited by this paper
• Premenstrual symptoms and premenstrual exacerbation in patients with psychiatric disorders

  2004cited by this paper
• Treatment effect of sibutramine compared to fluoxetine on leptin levels in polycystic ovary disease

  2004cited by this paper
• Androgens and Mood Dysfunction in Women: Comparison of Women With Polycystic Ovarian Syndrome to Healthy Controls

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study

  2003cited by this paper
• Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome.

  2003cited by this paper

• Mental Health Across the Menstrual Cycle in Polycystic Ovary Syndrome: Insights and Implications

  2024cites this paper